$5.01
0[0.00%]
At close: Mar 27
$5.01
0[0.00%]
PreMarket: 4:00PM EDT
Eagle Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Eagle Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | EGRX | Q1 | $1.26 | — | — | — | $66.31M | — | — | — | Get Alert |
04/09/2024 | AM | EGRX | Q4 | $1.10 | — | — | — | $60.70M | — | — | — | Get Alert |
11/08/2023 | AM | EGRX | Q3 | $1.12 | $1.07 | — | — | $65.90M | $64.51M | — | — | Get Alert |
08/08/2023 | AM | EGRX | Q2 | $1.56 | $1.05 | $1.18 | 12.38% | $74.14M | $59.35M | $64.65M | 8.92% | Get Alert |
05/09/2023 | AM | EGRX | Q1 | $4.04 | $1.05 | $1.26 | 20.00% | $115.87M | $63.29M | $66.31M | 4.76% | Get Alert |
03/13/2023 | AM | EGRX | Q4 | $0.85 | $0.83 | $1.10 | 32.53% | $42.32M | $64.26M | $60.70M | -5.54% | Get Alert |
11/07/2022 | AM | EGRX | Q3 | $0.56 | $0.91 | $1.12 | 23.08% | $39.85M | $62.08M | $65.90M | 6.15% | Get Alert |
08/09/2022 | AM | EGRX | Q2 | $0.93 | $3.36 | $1.56 | -53.57% | $48.12M | $116.89M | $74.14M | -36.58% | Get Alert |
05/09/2022 | AM | EGRX | Q1 | $0.24 | $3.88 | $4.04 | 4.12% | $41.25M | $123.33M | $115.87M | -6.05% | Get Alert |
03/07/2022 | AM | EGRX | Q4 | $0.96 | $0.94 | $0.85 | -9.57% | $49.92M | $51.08M | $42.32M | -17.15% | Get Alert |
11/09/2021 | AM | EGRX | Q3 | $1.17 | $0.83 | $0.56 | -32.53% | $49.93M | $46.40M | $39.85M | -14.11% | Get Alert |
08/09/2021 | AM | EGRX | Q2 | $0.57 | $0.80 | $0.93 | 16.25% | $41.94M | $45.86M | $48.12M | 4.94% | Get Alert |
05/10/2021 | AM | EGRX | Q1 | $0.84 | $0.65 | $0.24 | -63.08% | $46.02M | $45.41M | $41.25M | -9.16% | Get Alert |
03/02/2021 | AM | EGRX | Q4 | $0.48 | -$0.17 | $0.96 | 664.71% | $48.26M | $53.16M | $49.92M | -6.10% | Get Alert |
11/02/2020 | AM | EGRX | Q3 | $0.26 | $0.28 | $1.17 | 317.86% | $41.15M | $47.02M | $49.93M | 6.18% | Get Alert |
08/10/2020 | AM | EGRX | Q2 | $0.84 | $0.26 | $0.57 | 119.23% | $56.70M | $42.28M | $41.94M | -0.81% | Get Alert |
05/11/2020 | AM | EGRX | Q1 | $1.01 | $0.57 | $0.84 | 47.37% | $49.78M | $51.10M | $46.02M | -9.94% | Get Alert |
03/02/2020 | AM | EGRX | Q4 | $1.20 | $0.49 | $0.48 | -2.04% | $56.05M | $49.07M | $48.26M | -1.65% | Get Alert |
11/12/2019 | AM | EGRX | Q3 | $1.18 | $0.57 | $0.26 | -54.39% | $51.34M | $48.49M | $41.15M | -15.14% | Get Alert |
Eagle Pharmaceuticals (EGRX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.
The Actual EPS was $0.00, which missed the estimate of $1.07.
The Actual Revenue was $0K, which missed the estimate of $64.5M.
Browse earnings estimates, EPS, and revenue on all stocks.